| Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c. Abcb4-/-mouse model of PFIC3 G Wei, J Cao, P Huang, P An, D Badlani, KA Vaid, S Zhao, DQH Wang, ... Journal of hepatology 74 (6), 1416-1428, 2021 | 42 | 2021 |
| Efficacy and safety of drugs for gastroparesis: systematic review and network meta-analysis MR Ingrosso, M Camilleri, J Tack, G Ianiro, CJ Black, AC Ford Gastroenterology 164 (4), 642-654, 2023 | 18 | 2023 |
| Automated whole slide image analysis for a translational quantification of liver fibrosis C Serdjebi, K Bertotti, P Huang, G Wei, D Skelton-Badlani, IA Leclercq, ... Scientific reports 12 (1), 17935, 2022 | 5 | 2022 |
| Circulating Mitochondrial DNA as a Diagnostic Biomarker for Predicting Disease Severity in Patients With Acute Pancreatitis W Yakah, I Shah, D Skelton-Badlani, SD Freedman, YV Popov, SG Sheth, ... Gastroenterology 164 (6), 1009-1011. e3, 2023 | 3 | 2023 |
| Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis D Beyoğlu, P Huang, D Skelton-Badlani, C Zong, YV Popov, JR Idle Cells 12 (3), 485, 2023 | 2 | 2023 |
| TGFbeta2 UPREGULATION ON REACTIVE CHOLANGIOCYTES LIMITS THE THERAPEUTIC EFFICACY OF TGFbeta TRAP RAP-1332 IN MOUSE MODELS OF CHRONIC BILIARY INJURY AND FIBROSIS P Huang, M Shipman, D Skelton-Badlani, R Chen, S Suragani, P Andre, ... HEPATOLOGY 78, S1532-S1533, 2023 | | 2023 |
| TRANSPOSON-BASED ONCOGENES INTEGRATION IN Abcb4 (Mdr2)-/-MICE RECAPITULATES HIGH SUSCEPTIBILITY TO CHOLANGIOCARCINOMA IN PRIMARY SCLEROSING CHOLANGITIS P Huang, W Gao, YV Popov, G Wei, J Kirkpatrick, Y Lin, L Tan, ... HEPATOLOGY 78, S1956-S1957, 2023 | | 2023 |
| SELECTIVE TARGETING OF INTEGRIN avbeta8 EFFECTIVELY SUPPRESSES TUMOR GROWTH IN THE NEW PSC-ASSOCIATED CHOLANGIOCARCINOMA MODEL (SB CCA. Mdr2-/-MOUSE) P Huang, W Gao, H Matta, D Skelton-Badlani, N Blanco, M Lu, B Lippa, ... HEPATOLOGY 78, S1951-S1952, 2023 | | 2023 |
| ASK1/p38 axis inhibition blocks the release of mitochondrial “danger signals” from hepatocytes and suppresses progression to cirrhosis and liver cancer Z Peng, G Wei, P Huang, H Matta, G Wen, P An, S Zhao, Y Lin, L Tan, ... Hepatology, 10.1097, 2023 | | 2023 |
| 1007 MITOCHONDRIAL DNA CIRCULATES IN THE SERUM OF PATIENTS WITH ALCOHOLIC LIVER DISEASE AND REFLECTS ONGOING LIVER INJURY MM ALENZI, D Skelton-Badlani, P Huang, ZG Jiang, Y Popov Gastroenterology 164 (6), S-1269-S-1270, 2023 | | 2023 |
| Tu1415 CIRCULATING MITOCHONDRIAL DNA IN ACUTE PANCREATITIS: A POTENTIAL EARLY NON-INVASIVE BIOMARKER FOR PREDICTING DISEASE SEVERITY? I Shah, W Yakah, D Skelton-Badlani, A Chhoda, P Huang, A Ahmed, ... Gastroenterology 164 (6), S-1047, 2023 | | 2023 |
| SPATIAL TRANSCRIPTOMICS REVEALS EXTENSIVE CELLULAR RESTRUCTURING AND THE TRANSCRIPTIONAL LANDSCAPE IN PRIMARY SCLEROSING CHOLANGITIS Y Pita-Juarez, L Martelotto, N Kalavros, A Ploumakis, D Badlani, P Huang, ... HEPATOLOGY 76, S197-S198, 2022 | | 2022 |
| A Single-Nucleus and Spatial Transcriptomics Atlas Reveals Sub-Clinical but Major Topological, Functional, and Regenerative Liver Disruption in Patients with Severe Covid-19 ZG Jiang, Y Pita-Juarez, J Hecht, S Niezen, A Myloserdnyy, D Karagkouni, ... Hepatology, S72-S73, 2022 | | 2022 |
| TIME-EFFICIENT AND RELIABLE AUTOMATED LIVER FIBROSIS QUANTIFICATION IN PRECLINICAL FIBROSIS MODELS USING WHOLE SLIDE IMAGING C Serdjebi, K Bertotti, P Huang, G Wei, D Badlani, D Barbes, B Lepoivre, ... HEPATOLOGY 74, 1095A-1096A, 2021 | | 2021 |
| SB CCA. Mdr2-/-, A NEW MOUSE MODEL OF CHOLANGIOCARCINOMA ARISING IN THE PSC-LIKE SETTINGS OF PROGRESSIVE BILIARY INJURY AND FIBROSIS P Huang, G Wei, S Zhao, D Badlani, K Vaid, L Chen, MM Petitjean, ... HEPATOLOGY 74, 712A-712A, 2021 | | 2021 |
| Newmouse model of cholangiocarcinoma arising in the setting of progressive biliary injury and fibrosis P Huang, G Wei, S Zhao, D Badlani, L Chen, M Petitjean, X Chen, ... JOURNAL OF HEPATOLOGY 75, S499-S500, 2021 | | 2021 |
